American pharmaceutical giant Eli Lilly has said it will crack down on suppliers who are selling fake versions of its unapproved weight loss drug retatrutide.
Social media companies TikTok and Meta have also intervened against black market sellers operating on their platforms.
The decision comes after a Channel 4 investigation found that patients have been able to buy fake versions of retatrutide on social media.1 The triple glucagon hormone receptor agonist drug is currently in phase 3 clinical trials, set to conclude in May 2026.2
As a glucagon-like peptide-1 receptor agonist, it is similar …